Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Skeletal Muscle-derived Cell Implantation for the Treatment of Fecal Incontinence: a Phase III, Randomized, Controlled, Double Blind, Two Armed Clinical Study

NCT04976153 is registered in ClinicalTrials.gov with Innovacell GmbH as lead sponsor.

NCT NCT04976153
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04976153 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Skeletal Muscle-derived Cell Implantation for the Treatment of Fecal Incontinence: a Phase III, Randomized, Controlled, Double Blind, Two Armed Clinical Study
Lead sponsor
Innovacell GmbH
Phase
Phase 3
Overall status
Recruiting
Start date
May 11, 2022
Completion date
March 31, 2028
Enrollment
290 (estimated)
Sites
34

Conditions

As the registry lists them; a condition with its own page is linked.

fecal incontinence